 |
 |

Dopamine Receptor Occupancy and Plasma Haloperidol Levels
Adam Wolkin, MD;
Jonathan D. Brodie, PhD, MD;
Fauozia Barouche, MD;
John Rotrosen, MD
Department of Psychiatry New York University Medical Center 550 First Ave New York, NY 10016
Alfred P. Wolf, PhD;
Michael Smith, MD;
Joanna Fowler, PhD
Department of Chemistry Brookhaven National Laboratory Upton, NY 11973
Thomas B. Cooper, MA
Nathan Kline Institute, Orangeburg, NY 10962
Arch Gen Psychiatry. 1989;46(5):482-483.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.—
The kinetics of receptor-ligand interaction predict a curvilinear relationship between free brain ckade (inset). 6 5 4 in 3 2 e d c e a m x o p p A i 0 10 20 30 40 50 60 Plasma Haloperidol Level, ng/mL 20 40 60 80 100 Plasma Haloperidol Level, ng/mL ligand concentration or neuroleptic plasma level and dopamine receptor occupancy. Based on positron emission tomography (PET) studies using 11C-raclopride in several subjects, Farde et al1 recently presented a theoretical binding curve for this relationship. Cambon et al2 derived a similar curvilinear relationship from 76Br-labeled bromospiperone PET scans of six subjects who had varying diagnoses and were receiving either haloperidol or thioproperazine.
We conducted similar studies using the D2 radioligand 18F-j!V methylspiperone (NMS) to estimate dopamine receptor availability in patients with schizophrenia. Subjects included patients who were not receiving neuroleptic therapy and others who were treated
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|